Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-3_11-cv-04494/USCOURTS-cand-3_11-cv-04494-37/pdf.json

Nature of Suit Code: 830
Nature of Suit: Patent
Cause of Action: 35:145 Patent Infringement

---

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

Gregory L. Diskant (admitted pro hac vice)

Eugene M. Gelernter (admitted pro hac vice)

PATTERSON BELKNAP WEBB & TYLER LLP

1133 Avenue of the Americas

New York, NY 10036-6710

Telephone: (212) 336-2000

Facsimile: (212) 336-2222

Email: gldiskant@pbwt.com

emgelernter@pbwt.com

Charles D. Hoffmann (admitted pro hac vice)

Sean R. Marshall (admitted pro hac vice)

HOFFMANN MARSHALL STRONG LLP

116 W 23rd Street, Suite 500

New York, NY 10011

Tel/Fax: (646) 741-4501

Email: charlie@hmscounsel.com

sean@hmscounsel.com

Susan Roader (S.B. #160897)

O’MELVENY & MYERS LLP

2765 Sand Hill Road

Menlo Park, CA 94025

Telephone: (650) 473-2600

Facsimile: (650) 473-2601

Email: sroeder@omm.com

Attorneys for Plaintiffs

UNITED STATES DISTRICT COURT 

NORTHERN DISTRICT OF CALIFORNIA

Case No. 11-cv-4494-WHO

Case No. 12-cv-6360-WHO

ORDER 

LIFESCAN, INC. and

LIFESCAN SCOTLAND, LTD., 

Plaintiffs, 

v. 

DECISION DIAGNOSTICS CORP., and 

PHARMATECH SOLUTIONS, INC., 

Defendants.

LIFESCAN, INC. and

JOHNSON & JOHNSON, 

Plaintiffs, 

v. 

DECISION DIAGNOSTICS CORP.,

PHARMATECH SOLUTIONS, INC., 

Defendants.

Case 3:11-cv-04494-WHO Document 489 Filed 06/19/15 Page 1 of 2
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

-2-

Pursuant to the Court's order (D.E. 477), Plaintiffs LifeScan Inc. and LifeScan Scotland Ltd. 

(collectively, "LifeScan") submit this proposed order.

WHEREAS LifeScan has alleged in these actions that Defendants Decision Diagnostics 

Corp. and PharmaTech Solutions, Inc. (collectively "PharmaTech"): (1) infringe U.S. Patent Nos. 

5,708,247 ('247 patent), 6,241,862 ('862 patent), and 7,250,105 ('105 patent) in the 11-4494 Case

and (2) have violated the Lanham Act and related state law provisions in the 12-6360 Case; and

WHEREAS LifeScan has advised the Court in a Motion for Administrative Relief (D.E. 469) 

that it desires to narrow the issues for trial by voluntarily dismissing (a) its claim for infringement of 

the '247 patent and its claims for monetary damages on the '862 patent in the 11-4494 Case and 

(b) all of its claims for monetary damages in the 12-6360 Case; 

Having considered Plaintiffs' Motion for Administrative Relief (D.E. 469), Defendants' 

opposition (D.E. 470), and argument by counsel at the May 5, 2015 Case Management Conference, 

and for good cause shown, IT IS ORDERED THAT:

1. LifeScan's claim that PharmaTech infringes the '247 patent, namely Count I of LifeScan's 

First Amended Complaint (D.E. 170) in the 11-4494 Case, is DISMISSED WITH 

PREJUDICE.

2. LifeScan's claim for monetary damages based on infringement of the '862 patent in the 

11-4494 Case is DISMISSED WITH PREJUDICE.

3. LifeScan's claim for monetary damages based on the Lanham Act and related state law 

provisions in the 12-6360 Case is DISMISSED WITH PREJUDICE.

4. The stays previously entered in the 11-4494 Case remain in effect.

5. Cases 11-4494 and 12-6360 are otherwise consolidated for discovery and trial pursuant to 

Rule 42 of the Federal Rules of Civil Procedure.

SO ORDERED.

Dated: June 19, 2015

_______________________

Hon. William H. Orrick 

United States District Judge

Case 3:11-cv-04494-WHO Document 489 Filed 06/19/15 Page 2 of 2